Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alteration of cholesterol distribution at the plasma membrane of cancer cells: From evidence to pathophysiological implication and promising therapy strategy. | Front Physiol | 2022 | 36439249 | PubTator, text mining | PubMed |
| DPA promotes hBMSCs osteogenic differentiation by miR-9-5p/ERK/ALP signaling pathway. | Int J Med Sci | 2022 | 36438924 | PubTator, text mining | PubMed |
| Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease. | J Clin Med | 2022 | 36431326 | PubTator, text mining | PubMed |
| MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor. | Int J Mol Sci | 2022 | 36430972 | PubTator, text mining | PubMed |
| Regulation of Cholesterol Metabolism by Phytochemicals Derived from Algae and Edible Mushrooms in Non-Alcoholic Fatty Liver Disease. | Int J Mol Sci | 2022 | 36430146 | PubTator, text mining | PubMed |
| Circulating Long Non-Coding RNAs Could Be the Potential Prognostic Biomarker for Liquid Biopsy for the Clinical Management of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428681 | PubTator, text mining | PubMed |
| Circulating mir-200c and mir-33a may be used as biomarkers for predicting high fructose corn syrup-induced fatty liver and vitamin D supplementation-related liver changes. | Turk J Med Sci | 2022 | 36422507 | PubTator, text mining | PubMed |
| Mechanisms and Outcomes of Metabolic Surgery in Type 2 Diabetes. | Metabolites | 2022 | 36422274 | PubTator, text mining | PubMed |
| Role of miR-199a-5p in the post-transcriptional regulation of ABCA1 in response to hypoxia in peritoneal macrophages. | Front Cardiovasc Med | 2022 | 36407436 | PubTator, text mining | PubMed |
| Prioritization of microRNA biomarkers for a prospective evaluation in a cohort of myocardial infarction patients based on their mechanistic role using public datasets. | Front Cardiovasc Med | 2022 | 36407428 | PubTator, text mining | PubMed |
| Downregulation of hsa-miR-135b-5p Inhibits Cell Proliferation, Migration, and Invasion in Colon Adenocarcinoma. | Genet Res (Camb) | 2022 | 36407085 | PubTator, text mining | PubMed |
| Identification of core genes in prefrontal cortex and hippocampus of Alzheimer's disease based on mRNA-miRNA network. | J Cell Mol Med | 2022 | 36401602 | PubTator, text mining | PubMed |
| MicroRNAs as immune regulators and biomarkers in tuberculosis. | Front Immunol | 2022 | 36389769 | PubTator, text mining | PubMed |
| microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection. | Front Cell Infect Microbiol | 2022 | 36389170 | PubTator, text mining | PubMed |
| Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers. | Front Oncol | 2022 | 36387174 | PubTator, text mining | PubMed |
| Circ_0084043-miR-134-5p axis regulates PCDH9 to suppress melanoma. | Front Oncol | 2022 | 36387162 | PubTator, text mining | PubMed |
| Reticulated Platelets and Their Relationship with Endothelial Progenitor Cells during the Acute Phase of ST-Elevation Myocardial Infarction. | J Clin Med | 2022 | 36362823 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity. | Int J Mol Sci | 2022 | 36362356 | PubTator, text mining | PubMed |
| Crosstalk between Tumor-Associated Macrophages and MicroRNAs: A Key Role in Tumor Microenvironment. | Int J Mol Sci | 2022 | 36362044 | PubTator, text mining | PubMed |
| Targeting Immune Senescence in Atherosclerosis. | Int J Mol Sci | 2022 | 36361845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=18